United States · FDA National Drug Code directory
Febuxostat
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0054-0413_bbddff32-f902-4e38-94fb-a1b903d69ee8
- Product NDC
- 0054-0413
- Form
- TABLET
- Composition / generic term
- Febuxostat
- Labeler
- Hikma Pharmaceuticals USA Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20191111
- Source listing expiry
- 20261231
Source-listed ingredients
- FEBUXOSTAT — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (0054-0413-13) · 0054-0413-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →